Board clears Rs 600 cr QIP; Q1 PAT up 37% YoY

Fund Raising View source PDF Explain this filing

NEOGEN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.3%Reaction day

₹2055.00

prior close

₹2135.00

announcement price

After-mkt

timing

Nifty Microcap 250market+1.3%-1.0% vs market

Specialty Chemicals peers, median of 94sector+1.8%-1.5% vs sector

On the reaction day the stock moved 1.0 pts less than Nifty Microcap 250 and 1.5 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-3.4

10m

-3.5

15m

-2.3

30m

-1.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.3+1.3-1.0+1.8-1.5

Next day

-1.6+0.0-1.6+0.6-2.1

-0.4+0.5-0.9+0.9-1.4

-3.1-0.1-3.0-0.0-3.1

-1.9+1.0-3.0+0.1-2.0

-0.7+2.4-3.1+1.3-2.1

-2.1+4.1-6.2+1.9-4.0

15d

+10.1+5.1+5.0+1.6+8.5

+8.4+5.8+2.6+2.7+5.8

+16.6+4.5+12.1+4.0+12.6

+6.1-2.4+8.5-5.0+11.1

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 94Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Neogen Chemicals board approved raising up to Rs 600 cr via QIP or other permissible modes. Q1 FY27 standalone revenue rose 37% YoY to Rs 252.28 cr; PAT up 37% to Rs 19.44 cr. Consolidated PAT grew 67% to Rs 17.11 cr. 37th AGM on Aug 21, 2026. Crisil downgraded NCD ratings; coupon rose from 10.50% to 11% on Rs 200 cr NCDs. Rs 161 cr preferential issue to promoter group was completed in April.

Likely market impact

Potential equity dilution from Rs 600 cr QIP; strong Q1 results are positive, but NCD downgrade raises borrowing costs.